Biological Rhythms in Blood Markers May Complicate Anaemia Diagnosis

The human body clock may be influencing the accuracy of blood tests used to diagnose anaemia. Recent findings suggest that key blood markers are not static, but instead fluctuate according to circadian and seasonal rhythms, potentially leading to missed diagnoses.

Anaemia occurs when a patient has an insufficient number of red blood cells or a lack of haemoglobin, the essential protein that carries oxygen throughout the body. Blood test results for iron status—including serum iron and ferritin—exhibit diurnal variation. Data indicate that these values often peak in the morning, meaning a test taken at different times of the day could yield significantly different results.

The Role of Chronobiology

This phenomenon is rooted in chronobiology, the study of biological rhythms. Beyond the daily cycle, hematological parameters and blood iron homeostasis can also show seasonal variation. These shifts are often influenced by environmental factors, regional climates, and changes in diet throughout the year. Diurnal variation in blood markers is a known occurrence, where levels swing based on the body's internal clock.

Clinical Implications

Because these markers shift, a single-point-in-time test may act as an unreliable diagnostic tool. If a patient's levels happen to be at a biological peak during their specific testing window, they may appear to be within a normal range despite being clinically anaemic at other times. This is compounded by systemic issues in healthcare delivery; research indicates that standardized inpatient diagnostic approaches for anaemia are often lacking, which contributes to a high prevalence of unidentified cases within hospital settings.

Future Outlook

While the core fact of blood marker fluctuation is confirmed, medical experts are still evaluating the extent to which these rhythms contribute to missed diagnoses in routine clinical practice. Some researchers suggest that this 'body clock' effect could be a reason why some cases go undetected, though this remains a specific hypothesis rather than a broad clinical consensus.

Moving forward, the medical community may need to consider whether diagnostic thresholds should account for these natural dips and peaks. By integrating chronobiological data into testing protocols, clinicians may better ensure that patients suffering from fatigue and oxygen-delivery issues receive proper treatment. This shift would move the industry away from a static snapshot of health toward a more dynamic understanding of how blood chemistry evolves over hours and months.